Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
The EU is reassessing its Cosmetic Regulation through a 2025 Fitness Check. Discover what this means for industry, safety, animal testing, and sustainability alignment.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
The amendment to fragrance allergen regulations aims to enhance consumer safety by requiring individual labeling of 81 allergens in cosmetic products. It introduces new concentration thresholds and updates ingredient names for clarity. A transition period is set for compliance, with digital labeling as a future solution.
The OECD has established guidelines for chemical testing to ensure safety. PEPPER, a program under SNPE, aims to fill gaps in endocrine disruptor qualification and regulation. Learn more about these initiatives and their importance in ensuring chemical safety.
The European Commission proposes restricting D4, D5, and D6 in cosmetics to protect the environment from their harmful, bioaccumulative effects. The regulation, set for adoption by the end of 2023, aims to reduce emissions and promote sustainable practices in the cosmetics industry.
Learn about the latest IFRA standards impacting cosmetic and homecare products. Discover new restrictions and additions to perfume ingredients. Find out about the transition period and how to stay compliant with the updated standards.
Learn the difference between dietary supplements and medications, and the risks associated with using medicinal plants in supplements. ANSES has developed a tool to help healthcare professionals inform consumers. Visit their website for more information.
The European Commission has authorized specific uses of 4-tert-OPnEO and 4-NPnEO, substances of very high concern, for in vitro diagnostic and life science kits until 2031. These substances, used in various industrial and medical applications, are listed due to their environmental risks.
